Display Settings:

Format

Send to:

Choose Destination

    Virol J. 2008 Jul 11;5:80.

    Epitope characterization of the protective monoclonal antibody VN04-2 shows broadly neutralizing activity against highly pathogenic H5N1.

    Lim AP, Wong SK, Chan AH, Chan CE, Ooi EE, Hanson BJ.

    Defence Medical and Environmental Research Institute, DSO National Laboratories, 27 Medical Dr, 117510, Singapore. lpeichie@dso.org.sg

    The monoclonal antibody VN04-2 was previously shown to protect mice against lethal A/Vietnam/1203/04 H5N1 virus challenge when administered pre- and post-infection. In this study, we characterized the binding requirements of this antibody using direct binding to hemagglutinin and neutralization assays with H5N1 virus-like particles (H5N1-VLP) of eight recent H5N1 strains representing the major mutations within the 140s antigenic loop. Binding was clade independent and 3 mutations within this antigenic region are required before escape is possible, suggesting that apart from the H5N1 viruses circulating in Indonesia, VN04-2 may provide protection against H5N1 viruses from all other regions.

    PMID: 18616831 [PubMed - indexed for MEDLINE]

    PMCID: PMC2481255

    Supplemental Content

    Click here to read Click here to read